Pain management is a critical component of patient care.
Penthrox® (methoxyflurane) is a non-narcotic inhalational analgesic that is self-administered by conscious haemodynamically stable patients (under supervision) via the hand-held Penthrox® Inhaler to provide relief.
Penthrox® (methoxyflurane) has been clinically studied to assess the level of relief provided to patients (refer to Resource Centre - Clinical Studies and References).
If prescribed, Penthrox® (methoxyflurane) provides healthcare professionals with the ability to provide relief to their patients before, during and immediately after medical treatment.
Please review the full Product Information (PI) before prescribing.
For more information, please feel free to Contact Us.
Clinical Development Program
Several clinical trials in a variety of settings (including pre-hospital, emergency, oncology, radiology, dentistry and aesthetic medicine) are currently underway to assess the safety and efficacy of methoxyflurane in the management of pain.
MDI are interested in speaking with healthcare professionals who would like to undertake research in the area of acute analgesia using Penthrox® (methoxyflurane).
For further information, please feel free to Contact Us.
|
Product Information Sheet
Pain Relief / Analgesia
